Peptonic Medical intends to carry out a rights issue of approximately SEK 42 million and raises loan financing
Peptonic Medical AB (publ) ("PMED" or "the Company") announces today, November 4[th] , 2021, the intention to carry out a rights issue of units consisting of shares and warrants of series TO1 ("Unit") with preferential rights for the Company's existing shareholders (the "Rights Issue"). The proceeds from the Rights Issue and the warrants will mainly be used for the acquisition of Common Sense, for continued commercial launch and international expansion of the VagiVital and Lunettes product series as well as for the development of new products, including clinical studies. The Rights